• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

GRN No. 361

Substance: 1,4-α-D-glucan branching enzyme preparation
Intended Use: Use as an enzyme to catalyze the production of modified food starch ingredients including highly branched cyclic dextrins and enzymatically-synthesized glycogen
Basis: Scientific procedures
Notifier: Takashi Kuriki
Ezaki Glico Co., Ltd.
4-6-5, Utajima Nishioyogogawa
Osaka
JAPAN
Date of filing: Nov 18, 2010
GRAS Notice (releasable information): 361
Date of closure / FDA's Letter: Jan 31, 2011
At notifier's request, FDA ceased to evaluate the notice
-
-